Decellularization of bovine anterior cruciate ligament tissues minimizes immunogenic reactions to alpha-gal epitopes by human peripheral blood mononuclear cells

Knee

Volumn 19, Issue 5, 2012, Pages 672-675

  Yoshida, Ryu ^a   Vavken, Patrick ^a   Murray, Martha M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Anterior cruciate ligament; Graft rejection; Inflammation; Tissue engineering; Wound healing

Indexed keywords

ALPHA GALACTOSIDASE; DEOXYRIBONUCLEASE; EPITOPE; GLYCODEOXYCHOLIC ACID; INTERLEUKIN 6; OCTOXINOL; RIBONUCLEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ANTIBODY DETECTION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; DECELLULARIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; KNEE LIGAMENT SURGERY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TISSUE ENGINEERING; WOUND HEALING;

ALPHA-GALACTOSIDASE; ANIMALS; ANTERIOR CRUCIATE LIGAMENT; BIOCOMPATIBLE MATERIALS; CATTLE; DISEASE MODELS, ANIMAL; EPITOPES; HUMANS; KNEE INJURIES; LEUKOCYTES, MONONUCLEAR; TISSUE ENGINEERING; WOUND HEALING;

EID: 84865373920     PISSN: 09680160     EISSN: 18735800     Source Type: Journal    
DOI: 10.1016/j.knee.2011.08.002     Document Type: Article

References (27)

1. Kibler W.B. Orthopaedic knowledge update 4: sports medicine 2009, American Academy of Orthopaedic Surgeons, Rosemont IL, p135.
2. Neuman P., Englund M., Kostogiannis I., Fridén T., Roos H., Dahlberg L.E. Prevalence of tibiofemoral osteoarthritis 15years after nonoperative treatment of anterior cruciate ligament injury: a prospective cohort study. Am J Sports Med 2008, 36:1717-1725.
3. Miller S.L., Gladstone J.N. Graft selection in anterior cruciate ligament reconstruction. Orthop Clin North Am 2002, 33:675.
4. Liden M., Sernert N., Rostgard-Christensen L., Kartus C., Ejerhed L. Osteoarthritic changes after anterior cruciate ligament reconstruction using bone-patellar tendon-bone or hamstring tendon autografts: a retrospective, 7-year radiographic and clinical follow-up study. Arthroscopy 2008, 24:899-908.
5. Murray M.M., Spindler K.P., Abreu E., Muller J.A., Nedder A., Kelly M., et al. Collagen platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res 2007, 25:81-91.
6. Murray M.M., Spindler K.P., Ballard P., Welch T.P., Zurakowski D., Nanney L.B. Enhanced histologic repair in a central wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold. J Orthop Res 2007, 25:1007-1017.
7. Murray M.M., Spindler K.P., Devin C., Snyder B.S., Muller J., Takahashi M., et al. Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL. J Orthop Res 2006, 24:820-830.
8. Spindler K.P., Murray M.M., Carey J.L., Zurakowski D., Fleming B.C. The use of platelets to affect functional healing of an anterior cruciate ligament (ACL) autograft in a caprine ACL reconstruction model. J Orthop Res 2009, 27:631-638.
9. Fufa D., Shealy B., Jacobson M., Kevy S., Murray M.M. Activation of platelet-rich plasma using soluble type I collagen. J Oral Maxillofac Surg 2008, 66:684-690.
10. Fleming B.C., Spindler K.P., Palmer M.P., Magarian E.M., Murray M.M. Collagen-platelet composites improve the biomechanical properties of healing ACL grafts in a porcine model. Am J Sports Med 2009, 37:1554-1563.
11. Pietramaggiori G., Scherer S.S., Mathews J.C., Gennaoui T., Lancerotto L., Ragno G., et al. Quiescent platelets stimulate angiogenesis and diabetic wound repair. J Surg Res 2010, 160:169-177.
12. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.
13. Robayo L.M., Mouin V.J., Tremblay P., Cloutier R., Lamontagne J., Larkin A.M., et al. New ligament healing model based on tissue-engineered collagen scaffolds. Wound Repair Regen 2011, 19:38-48.
14. Sandmann G.H., Eichhorn S., Vogt S., Adamczyk C., Aryee S., Hoberg M., et al. Generation and characterization of a human acellular meniscus scaffold for tissue engineering. J Biomed Mater Res A 2009, 91:567-574.
15. Rieder E., Seebacher G., Kasimir M.T., Eichmair E., Winter B., Dekan B., et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005, 111:2792-2797.
16. Chen R.N., Ho H.O., Tsai Y.T., Sheu M.T. Process development of an acellular dermal matrix (ADM) for biomedical applications. Biomaterials 2004, 25:2679-2686.
17. Courtman D.W., Pereira C.A., Kashef V., McComb D., Lee J.M., Wilson G.J. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994, 28:655-666.
18. Farhat W.A., Chen J., Haig J., Antoon R., Litman J., Sherman C., et al. Porcine bladder acellular matrix (ACM): protein expression, mechanical properties. Biomed Mater 2008, 3:025015.
19. Dumont C.E., Hentz V.R. Enhancement of axon growth by detergent-extracted nerve grafts. Transplantation 1997, 63:1210-1215.
20. Vavken P., Joshi S., Murray M.M. TRITON-X is most effective among three decellularization agents for ACL tissue engineering. J Orthop Res 2009, 27:1612-1618.
21. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005, 83:674-686.
22. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993, 14:480.
23. Stone K.R., Abdel-Motal U.M., Walgenbach A.W., Turek T.J., Galili U. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 2007, 83:211-219.
24. Friedman T., Shimizu A., Smith R.N., Colvin R.B., Seebach J.D., Sachs D.H., et al. Human CD4+ T cells mediate rejection of porcine xenografts. J Immunol 1999, 162:5256-5262.
25. Gaines Das R.E., Brügger P., Patel M., Mistry Y., Poole S. Monocyte activation test for pro-inflammatory and pyrogenic contaminants of parenteral drugs: test design and data analysis. J Immunol Methods 2004, 288:165-177.
26. Galili U. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Transfus Apher Sci. 2006 Aug, 35(1):45-58.
27. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 2008, 20:109-116.